Isabella Hornick is an Editorial Assistant at Environmental Post Ledger. She covers a range of topics within the realms of medicine and healthcare, with a particular focus on public health, mental health, diet and nutrition, and wellness programs. Isabella's work has been featured in notable publications including Environmental Post Ledger and Healio.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Isabella's articles predominantly focus on pulmonology, with a strong emphasis on citing data. To effectively reach out to her, consider providing well-researched and fact-based insights related to topics such as pulmonology, sleep disorders, respiratory health, and lung-related conditions backed by recent data or studies.
Given the scientific nature of Isabella's coverage, she may be interested in receiving pitches from experts in the field who can provide detailed analysis or commentary based on credible research findings. Additionally, considering the prevalence of COVID-19 stories in her articles, offering new developments or significant studies related to COVID-19 within the scope of pulmonology could also capture her interest.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Isabella Hornick
ORLANDO — Patients with COPD had larger improvements in FEV1 with a nebulized fixed-dose combination of indacaterol and glycopyrrolate vs. placebo, according to results presented at the American Thoracic Society International Conference.The long-acting beta-agonist indacaterol and the long-acting muscarinic antagonist glycopyrrolate make up AERO-007 (AeroRx Therapeutics), according to the
By: Isabella Hornick, Kristen Dowd
ORLANDO — Pregnant patients with a periconception eosinophil count of at least vs. less than 300 cells/μL had more asthma exacerbations while
By: Isabella Hornick
ORLANDO — Among adults with obstructive sleep apnea who do not meet the CMS requirement for CPAP coverage, 36% used CPAP at 12 months, according to data presented at the American Thoracic Society International Conference.Notably, CMS only covers CPAP for patients with OSA if they use it for at least 4 hours on 70% of nights during a 30-day window within the first 90 days, according to
By: Isabella Hornick
Across three early cow’s milk formula exposure groups vs. no exposure, none were significantly linked to the odds for cow’s milk allergy or sensitization at 1 year, according to study findings.“There was no clear evidence of an association between very early transient exposure and the risk of any cow’s milk allergy outcomes at age 1 or 6 years,” Erin Pitt, PhD,
By: Kristen Dowd, Isabella Hornick
ORLANDO — In U.S. hospital encounters for COPD, there was a rise in 30-day revisits in hospitals that underwent private equity acquisition, according to data presented at the American Thoracic Society International Conference.
By: Isabella Hornick, Kristen Dowd
ORLANDO — At this year's American Thoracic Society International Conference, Joy Nkiru Eze, MBBS, MPH, MSc, MPhil received the Philip Hopewell Prize for Global Respiratory Health Research.
By: Kristen Dowd, Scott P. Commins, Isabella Hornick
A pilot study, supported by the Food Allergy Fund, plans to assess metformin as a treatment in patients with peanut allergy.
By: Isabella Hornick, Kristen Dowd
ORLANDO — Adults with vs. without pulmonary arterial hypertension had a significantly heightened risk for developing a new mental health condition in the 12 months following diagnosis, according to a poster presented here.
By: Isabella Hornick, Kristen Dowd
ORLANDO — Both patients with asthma who switched from mepolizumab/benralizumab to depemokimab and patients who continued mepolizumab/benralizumab had low annualized exacerbation rates, according to results presented here.
By: Isabella Hornick
ORLANDO — Nearly 70% of patients with positional obstructive sleep apnea who discontinued positional therapy after achieving disease control still had control at 1 year, according to findings presented here.“These findings support a more personalized approach to OSA,” Irene Cano-Pumarega, MD, PhD, pneumonologist and head of the sleep unit at Ramn y Cajal Hospital in Madrid, told
